Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)

v3.25.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2025
USD ($)
shares
Dec. 31, 2024
USD ($)
shares
Mar. 31, 2025
£ / shares
Dec. 31, 2024
£ / shares
CONDENSED CONSOLIDATED BALANCE SHEETS        
Marketable securities - amortized cost $ 18,512 $ 60,451    
Marketable securities - Net of allowance for expected credit losses 0 0    
Allowance for expected credit losses 0 0    
Operating lease right-of-use assets, accumulated amortization 19,080 17,750    
Property, plant and equipment, accumulated depreciation 70,048 51,893    
Intangibles, accumulated amortization $ 5,819 $ 5,567    
Common stock, par value | £ / shares     £ 0.001 £ 0.001
Common stock, shares authorized | shares 2,039,252,874 2,039,252,874    
Common stock, shares issued | shares 1,547,093,808 1,535,653,620    
Common stock, shares outstanding | shares 1,547,093,808 1,535,653,620